|
Published: Oct 1, 2001 - 316 Pages
Table of Contents:
Chapter One
Executive Summary
- Introduction
- Scope and Methodology
- Size and Growth of the Market
- Market Trends
- The Nature of the Industry
Chapter Two
Introduction
- Background
- Market Erosion
- Clinical Relevance
- Cost-Benefit Relationships
- Scientific Limitations
- Fitting the Environment
- Genomics
- The Relationship of Genes to Disease
- The Spread of Functional Genomics
Chapter Three
Molecular Diagnostics Technologies
- Background
- Amplification Technologies
- Probe Technologies
- Microchip Technologies
- Electrophoretic Technologies
- Blotting Technologies
Chapter Four
Applications of Molecular Diagnostics
- The Testing Environment
- Infectious Diseases
- Blood Banking
- Genetic Diseases
- Cancer
- Pharmacogenetics
- Commercial Efforts
Chapter Five
The Market Dynamics of Molecular Diagnostics
- Market Size and Trending
- Competition
- The Future Revival?
Chapter Six
Company Profiles
- Abbott Diagnostics, Inc
- Affymetrix Inc
- Agilent Technologies, Inc
- Applied Biosystems Group
- Cepheid, Inc
- Chiron Corporation
- diaDexus, LLC
- Digene Corp
- Gene Logic, Inc
- Gen-Probe, Incorporated
- Innogenetics NV
- MitoKor, Inc
- Myriad Genetics, Inc
- Nanogen, Inc
- Orchid Biosciences, Inc
- Perkin-Elmer Corp
- Roche Diagnostics Division/Roche Molecular Systems
- Visible Genetics
- Vysis
Chapter Seven
Conclusions and Strategic Implications
Appendix A
Glossary
Appendix B
Company Names And Addresses
List of Exhibits
Chapter One: Executive Summary
- Table 1-1: Molecular Diagnostics Testing Potential in the United States: 1999 - 2007
- Figure 1-1: Distribution of Molecular Diagnostics Testing Potential by Application in the United States: 2001
- Table 1-2: Common Molecular Diagnostics Tests
- Table 1-3: Historic and Forecast Total Available United States Markets for Molecular Diagnostics: 1999 - 2007
- Figure 1-2: Trending of the Historic and Forecast Total Available United States Markets for Molecular Diagnostics: 1999 - 2007
- Table 1-4: Historic and Forecast Serviceable Available United States Markets for Molecular Diagnostics: 1999 - 2007
- Figure 1-3: Trending of the Historic and Forecast Serviceable Available United States Markets for Molecular Diagnostics: 1999 - 2007
- Table 1-5: Key Molecular Diagnostics Companies
Chapter Three: Molecular Diagnostics Technologies
- Table 3-1: Molecular Diagnostics Technologies
- Table 3-2: Gene Amplification Technologies
- Table 3-3: Signal Amplification Technologies
Chapter Four: Applications of Molecular Diagnostics
- Table 4-1: Home-Brew Molecular Diagnostics Assays at the Johns Hopkins University Hospital
- Table 4-2: Home-Brew Molecular Diagnostics Assays at the Magee-Womens Hospital/University of Pittsburgh
- Table 4-3: Home-Brew Molecular Diagnostics Assays at the University of Nebraska Medical Center
- Table 4-4: Home Brew Molecular Diagnostics Assays at the City of Hope National Medical Center
- Figure 4-1: Distribution of Molecular Diagnostics Testing by Application in the United States: 2001
- Table 4-5: Important Infectious Disease Testing Opportunities for Molecular Diagnostics in the United States: 1999 - 2007
- Figure 4-2: Trends in Molecular US Infectious Disease Testing in the United States: 1999 - 2007
- Table 4-6: Important Blood Banking Testing Opportunities for Molecular Diagnostics in the United States:
1999 - 2007
- Figure 4-3: Trends in Molecular Blood Banking Testing in the United States: 1999 - 2007
- Table 4-7: Common Hereditary Diseases
- Table 4-8: Important Genetic Disease Testing Opportunities for Molecular Diagnostics in the United States:
1999 - 2007
- Figure 4-4: Trends in Molecular Genetic Disease Testing in the United States: 1999 - 2007
- Table 4-9: Important Cancer Testing Opportunities for Molecular Diagnostics in the United States:
1999 - 2007
- Figure 4-5: Trends in Molecular Cancer Testing in the United States: 1999 - 2007
- Table 4-10: Important Pharmacogenetic Testing Opportunities for Molecular Diagnostics in the United States:
1999 - 2007
- Figure 4-6: Trends in Molecular Pharmacogenetics Testing in the United States: 1999 - 2007
Chapter Five: The Market Dynamics of Molecular Diagnostic
- Table 5-1: Historic and Forecast Total Available United States Markets for Molecular Diagnostics: 1999 - 2007
- Figure 5-1: Trending of the Historic and Forecast Total Available United States Markets for Molecular Diagnostics: 1999 - 2007
- Figure 5-2: Composition of the Historic and Forecast Total Available United States Markets for Molecular Diagnostics: 1999 - 2007
- Table 5-2: Breakdown of the Historic and Forecast Total Available United States Market for Molecular Diagnostics by Dollar Volume, Test Volume and Average Price Per Test: 1999 - 2007
- Table 5-3: Historic and Forecast Serviceable United States Markets for Molecular Diagnostics: 1999 - 2007
- Table 5-4: Comparison of the Total Available and Serviceable Available United States Markets for Molecular Diagnostics by Application Segment: 1999 - 2007
- Figure 5-3: Trending of the Historic and Forecast Serviceable United States Markets for Molecular Diagnostics: 1999 - 2007
- Figure 5-4: Composition of the Historic and Forecast Serviceable Available United States Markets for Molecular
Diagnostics: 1999 - 2007
- Figure 5-5: Closing the Gap Between the Total Available and Serviceable Available United States Markets for
Molecular Diagnostics: 1999 - 2007
- Table 5-5: Active Competitors in the United States Molecular Diagnostics Markets
- Figure 5-6: Estimated Market Shares in Molecular Diagnostics By Technology Segment: 2001
Abstract:
In recent years molecular diagnostics has become a growing part of the clinical laboratory. The trend will not only continue but will show significant growth in the future.
This report from Kalorama Information examines the current and future opportunities associated with Molecular Diagnostic Technologies. Areas covered include:
- Applications
- DNA-Based Technologies
- Genomics
- Amplification systems
- Probe technologies
- Chip-based technologies
- Protein-Based Technologies
- Proteomics
- Protein probes
- Chip-based technologies
Market size and share for traditional Molecular Diagnostic products and the commercial outlook for new and/or emerging technologies.
Get full details about this report >
|